Webinar description:
What risks does RbM introduce by itself? Why monitoring team does not accept the new RbM procedure? How should sites be involved in RbM process?
Now, we can tackle these questions.
We are going to review the definition of Risk-based Monitoring (RbM) in clinical research. Difference of definitions between FDA and EMA?
Answer “What it’s in it for me?” question. — Share real-life examples of the RbM application.
Identify the difficulties & potential pitfalls of RbM application.In our webinar, we will devote our attention to practical insights of implementation risk-based monitoring strategy and application of innovative software projects in this domain — controlled risks are manageable risks.
Leave A Comment
You must be logged in to post a comment.